There is significant relationship between Beijing genotype family strains and resistance to the first-line anti-tuberculosis drugs in the Iranian population

被引：7
|
作者：
Keikha, Masoud [1 ,2 ,3 ]
机构：
[1] Mashhad Univ Med Sci, Antimicrobial Resistance Res Ctr, Mashhad, Razavi Khorasan, Iran
[2] Mashhad Univ Med Sci, Fac Med, Dept Microbiol & Virol, Mashhad, Razavi Khorasan, Iran
[3] Mashhad Univ Med Sci, Student Res Comm, Mashhad, Razavi Khorasan, Iran
来源：
JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES | 2020年 / 19卷
关键词：
MYCOBACTERIUM-TUBERCULOSIS STRAINS; MULTIDRUG-RESISTANT; GENETIC DIVERSITY; ASSOCIATION; PREVALENCE; PATTERNS; MUTATIONS; LINEAGE; CHINA;
D O I：
10.1016/j.jctube.2020.100161
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Leukopenia during treatment with first-line anti-tuberculosis medication
    Lee, SW
    Lee, SM
    Yoo, CG
    Kim, YW
    Han, SK
    Shim, YS
    Yim, JJ
    RESPIRATION, 2005, 72 (06) : 660 - 661
  • [22] Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring
    Verbeeck, Roger K.
    Guenther, Gunar
    Kibuule, Dan
    Hunter, Christian
    Rennie, Tim W.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (08) : 905 - 916
  • [23] Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring
    Roger K. Verbeeck
    Gunar Günther
    Dan Kibuule
    Christian Hunter
    Tim W. Rennie
    European Journal of Clinical Pharmacology, 2016, 72 : 905 - 916
  • [24] Bile acids, lipid and purine metabolism involved in hepatotoxicity of first-line anti-tuberculosis drugs
    Liu, Linsheng
    Li, Xianglian
    Huang, Chenrong
    Bian, Yicong
    Liu, Xiaoxue
    Cao, Jun
    Qu, Wenhao
    Miao, Liyan
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (06) : 527 - 537
  • [25] Drug exposure of first-line anti-tuberculosis drugs in China: A prospective pharmacological cohort study
    Gao, Yazhou
    Forsman, Lina Davies
    Ren, Weihua
    Zheng, Xubin
    Bao, Ziwei
    Hu, Yi
    Bruchfeld, Judith
    Alffenaar, Jan-Willem
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (03) : 1347 - 1358
  • [26] Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs
    Martin, A
    Morcillo, N
    Lemus, D
    Montoro, E
    Telles, MAD
    Simboli, N
    Pontino, M
    Porras, T
    León, C
    Velasco, M
    Chacon, L
    Barrera, L
    Ritacco, V
    Portaels, F
    Palomino, JC
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2005, 9 (08) : 901 - 906
  • [27] Scientific and patient care evidence to change susceptibility breakpoints for first-line anti-tuberculosis drugs
    Pasipanodya, Jotam G.
    Srivastava, Shashikant
    Gumbo, Tawanda
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (05) : 706 - 707
  • [28] Effect of interval between food intake and drug administration at fasting condition on the plasma concentrations of first-line anti-tuberculosis drugs in Chinese population
    Wang, Jun
    Wang, Jing
    Du, Yadong
    Guo, Ru
    Han, Xiqin
    Wang, Qingfeng
    Pang, Yu
    Chu, Naihui
    MEDICINE, 2020, 99 (44)
  • [29] Molecular Basis of Resistance to First-Line Drugs of Mycobacterium tuberculosis/canettii Strains in Greece
    Florou, Zoi
    Mavroidi, Aggeliki
    Vatidis, George
    Daniil, Zoi
    Gourgoulianis, Konstantinos
    Petinaki, Efi
    MICROBIAL DRUG RESISTANCE, 2021, 27 (10) : 1389 - 1396
  • [30] The diagnostic accuracy of the GenoType® MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs
    Theron, Grant
    Peter, Jonny
    Richardson, Marty
    Barnard, Marinus
    Donegan, Sarah
    Warren, Rob
    Steingart, Karen R.
    Dheda, Keertan
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10):
12345